- $3.51bn
- $2.92bn
- $107.94m
- 55
- 10
- 23
- 19
Annual income statement for Arcellx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 110 | 108 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 32.1 | 65 | 191 | 200 | 246 |
| Operating Profit | -32.1 | -65 | -191 | -89.9 | -138 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -32.1 | -65 | -189 | -70 | -105 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -32.1 | -65 | -189 | -70.7 | -107 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -32.1 | -65 | -189 | -70.7 | -107 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -32.1 | -65 | -189 | -70.7 | -107 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.923 | -1.87 | -5.19 | -1.47 | -2 |
| Dividends per Share |